Screener
Ultragenyx Pharmaceutical RARE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on the most recent quarter.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's price / sales?
- Ultragenyx Pharmaceutical (RARE) reported price / sales of 4.6× in Q2 2026.
- How has Ultragenyx Pharmaceutical's price / sales changed year-over-year?
- Ultragenyx Pharmaceutical's price / sales decreased by 20.4% year-over-year, from 5.8× to 4.6×.
- What is the long-term trend for Ultragenyx Pharmaceutical's price / sales?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's price / sales has grown at a -37.6% compound annual growth rate (CAGR), from 34.8× to 3.3×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Ultragenyx Pharmaceutical's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude